Prothena | PRTA - Ebitda


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Prothena

Prothena reported $128K in EBITDA for its fiscal quarter ending in December of 2022.


Ebitda Change
Acadia Pharmaceuticals ACAD:US USD -53158000 7.58M
Agios Pharmaceuticals AGIO:US USD -88823000 8.54M
Akebia Therapeutics AKBA:US USD -15423000 19.71M
ALKERMES ALKS:US USD -28780000 27.88M
Alnylam Pharmaceuticals ALNY:US USD -135742000 38.56M
Amgen AMGN:US USD 3B 42M
Biogen BIIB:US USD 686.7M 312.1M
BioMarin Pharmaceutical BMRN:US USD 87.87M 87.82M
Bluebird Bio BLUE:US USD -83411000 8.1M
Exelixis EXEL:US USD 35.68M 77.82M
Immunic Inc. VTL:US USD -27219000 2.88M
Incyte Corp INCY:US USD 48.82M 62.76M
Intercept Pharmaceuticals ICPT:US USD -31543000 13.66M
Intra Cellular Therapies ITCI:US USD -48258000 1.03M
Ionis Pharmaceuticals IONS:US USD -110937000 93.44M
MacroGenics MGNX:US USD -35443000 50.66M
Nektar Therapeutics NKTR:US USD -34714000 2.99M
Neurocrine Biosciences NBIX:US USD 34.7M 73.1M
Regeneron Pharmaceuticals REGN:US USD 1.1B 195.4M
Seattle Genetics SGEN:US USD -136400000 297K
Ultragenyx Pharmaceutical RARE:US USD -148869000 8.2M
Vertex Pharmaceuticals VRTX:US USD 817.8M 254.1M
Xoma XOMA:US USD -9944000 3.83M